-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Crohn's disease (CD) is an inflammatory bowel disease that can affect any part of the gastrointestinal tract from the mouth to the anus
.
Symptoms usually include: abdominal pain, diarrhea (which may be bloody if the inflammation is severe), fever, and weight loss
Crohn's disease (CD) is an inflammatory bowel disease that can affect any part of the gastrointestinal tract from the mouth to the anus
Many patients who manage the FDA hope to have alternatives to long-term immunosuppressive therapies, such as therapeutic diets
The risk of CD is lower in people who eat the traditional Mediterranean diet (MD), which is rich in fresh fruits, vegetables, nuts, fish, and whole grains, and uses olive oil as the main source of fat
SCD and MD diet
Among them, one of the most commonly used therapeutic diets is the specific carbohydrate diet (SCD)
.
Small studies have provided preliminary evidence that using SCD or modified SCD can improve symptoms and reduce intestinal inflammation
Small studies have provided preliminary evidence that using SCD or modified SCD can improve symptoms and reduce intestinal inflammation
The study randomly selected 194 patients, of which 191 were included in the efficacy analysis
.
The results showed that the percentage of participants who followed MD and achieved symptom relief at week 6 was not better than that of SCD (SCD, 46.
The results showed that the percentage of participants who followed MD and achieved symptom relief at week 6 was not better than that of SCD (SCD, 46.
Primary and secondary results after 6 weeks of diet therapy
.
In addition, 8 of 23 participants (34.
8%) who used SCD achieved FC response, and 4 of 13 participants (30.
8%) who used MD achieved FC response (P = .
83)
.
Two of the 37 people who used SCD (5.
It can be seen that SCD is not superior to MD in terms of achieving symptom relief, FC response and CRP response
.
CRP reactions are not common
It can be seen that SCD is not superior to MD in terms of achieving symptom relief, FC response and CRP response
references:
A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn's Disease.
https://doi.
org/10.
1053/j.
gastro.
2021.
05.
047
Leave a message here